ADK.V

Today Equity.Guru founder, Chris Parry, speaks with Stefan Quenneville, Director of Life Sciences and Biotech Research at Echelon Wealth Partners, to get his take on Diagnos (ADK.V), a Canadian…
Diagnos (ADK.V) announced that their artificial intelligence program delivered world-class results in the GAMMA (Glaucoma GrAding from Multi-Modality imAges) contest, held alongside The Medical Imaging Computing and Computer-Assisted Intervention…
Diagnos (ADK.V) announced today that it has signed a 7-year contract with Juarez Health & Medical Tourism Cluster (“Cluster”), headquartered in Ciudad Juarez located in the State of Chihuahua,…
Diagnos (ADK.V) announced today that it has signed a 3-year contract with Cielo Vista Eye Clinic in Mexico. According to the contract, Diagnos will supply its CARA platform to…
In this episode, we talk about DIAGNOS (ADK.V), a publicly traded Canadian corporation with a mission to commercialize technologies combining contextual imaging, and traditional data mining thereby improving decision…
Chris Parry speaks with Andre Larente, president and CEO of DIAGNOS (ADK.V) to get an in-depth look at how their diabetic retinopathy screening services work and what it means…
Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public…
Diagnos (ADK.V) is definitely one of the companies with the coolest AI tech I have come across. I would use the word disruptive. And I like disruptive. I am…
Diagnos (ADK.V) today announced a contract renewal to provide its telemedicine platform based on CARA (Computer Assisted Retina Analysis) to Optina Diagnostics for an additional three-year period. “This contract…